Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers

Clinical trial NCT06736587 · RECRUITING

Trial details

NCT number: NCT06736587
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2024-12-10
Primary completion: 2026-12-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.